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lized PD fluid as the result of the raised pH and the loweredAffinity adsorption of glucose degradation products improves
RCOs levels.the biocompatibility of conventional peritoneal dialysis fluid.
Conclusion. Hydrazine-coupled epoxy-beads reduce the lev-Background. Reactive carbonyl compounds (RCOs) pres-
els of a variety of dicarbonyls and aldehydes present in heat-ent in peritoneal dialysis (PD) fluid have been incriminated in
sterilized glucose PD fluid to those in filter-sterilized PD fluid,the progressive deterioration of the peritoneal membrane in
without altering glucose, lactate, and electrolytes contents butlong-term PD patients. They are initially present in fresh con-
with a rise in pH. Incubated with PD effluents, it is equally ef-ventional heat-sterilized glucose PD fluid and are supplemented
fective in reducing the levels of serum-derived RCOs. RCO en-during dwell time by the diffusion of blood RCOs within the
trapping agents immobilized on affinity beads improve in vitroperitoneal cavity. In the present study, RCO entrapping agents
the biocompatibility of conventional heat-sterilized glucose PDwere immobilized on affinity beads to adsorb RCOs both in
fluid. Their clinical applicability requires further studies.fresh PD fluid and in PD effluent.
Methods. The RCO trapping potential of various compounds
was assessed in vitro first by dissolving them in the tested fluid
and subsequently after coupling with either epoxy- or amino- It has been hypothesized that peritoneal membrane
beads. The tested fluids include fresh heat-sterilized glucose deterioration during peritoneal dialysis (PD) [1–2] re-and non-glucose PD fluids, and PD effluent. Their RCOs con-
sults at least in part from the accumulation, both in PDtents, that is, glyoxal (GO), methylglyoxal (MGO), 3-deoxyglu-
fluid and in uremic blood, of glucose degradation prod-cosone (3-DG), formaldehyde, 5-hydroxymethylfuraldehyde,
acetaldehyde, and 2-furaldehyde were monitored by reverse- ucts (GDP) and reactive carbonyl compounds (RCOs)
phase high-pressure liquid chromatography. The biocompati- with their attendant generation of advanced glycation
bility of PD fluid was assessed by a cytotoxic assay with either end products (AGEs) [3–8].
human epidermoid cell line A431 cells or with primary cultured
Efforts thus far have been directed first toward thehuman peritoneal mesothelial cells.
production of GDP-free PD fluids, such as icodextrin orResults. Among the tested RCO entrapping agents, hydra-
zine coupled to epoxy-beads proved the most efficient. It low- amino acids solution [9–11], or dual bag systems with a
ered the concentrations of three dicarbonyl compounds (GO, higher pH [12–15]. Subsequently, drugs known to inhibit
MGO, and 3-DG) and those of aldehydes present in fresh heat- AGE formation [16–18] have been shown to reduce
sterilized glucose PD fluid toward the low levels observed in
GDP levels in fresh glucose PD fluids [19]. Their use,filter-sterilized glucose PD fluid. It did not change the glucose
however, is limited by their potential toxicity [20] shouldand electrolytes concentration of the PD fluid but raised its
they diffuse from the peritoneal cavity into circulatingpH from 5.2 to 5.9. Hydrazine-coupled epoxy-bead also low-
ered the PD effluent content of total RCOs, measured by the blood. Both approaches unfortunately fail to cope with
2,4-dinitrophenylhydrazone (DNPH) method. The cytotoxicity the diffusion of RCOs from blood into the peritoneal
of heat-sterilized PD fluid incubated with hydrazine-coupled cavity during the exchange.epoxy-beads was decreased to the level observed in filter-steri-
The present study pursues the two goals: first, to iden-
tify low-molecular-weight compounds containing amino
groups able to react with RCOs and, second, to coupleKey words: reactive carbonyl compounds, carbonyl stress, hydrazine,
uremic blood, affinity bead, dialysate, peritoneal membrane deterioration. them with either epoxy- or amino-beads to prevent their
diffusion from the dialysate, outside the peritoneal cavity.Received for publication April 30, 2002
We and others previously demonstrated that compoundsand in revised form July 21, 2002
Accepted for publication August 28, 2002 with either hydrazine or amino groups effectively trap
RCOs [19, 21, 22]. Thus, two classes of well known and 2003 by the International Society of Nephrology
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commercially available compounds were selected: two epoxy-bead with 1 mol/L ethanolamine (Sigma, St. Louis,
MO, USA), overnight at pH 8.0 at room temperature.hydrazine derivatives (N,N-diaminoguanidine monohydro-
chloride, hydrazine monohydrate) and six amino group For coupling with amino-bead [24], the amino groups
of l-cystine, 2,3-diaminopropionic acid, or 3,4-diamino-containing compounds (hydroxylamine, oxamide, mela-
mine, l-cystine, 2,3-diaminopropionic acid, 3,4-diamino- benzoic acid were protected by di-t-butyldicarbonate
(Boc; Wako Pure Chemicals) as described elsewhere [25].benzoic acid). We demonstrate that hydrazine bound to
epoxy-beads markedly lowers RCOs both in fresh PD The Boc-ligand (10 mmol each) dissolved in 1 mL of
ethanol was incubated at room temperature for 24 hoursfluid and in PD effluent, and reduces the cytotoxicity of
PD fluid. with 1 g dried amino-bead in 1 mL of distilled water, in
the presence of 1 mL of 0.3 mol/L 1-ethyl-3-(3-dimethyl-
amino-propyl)-carbodiimide (Nacalai Tesque, Kyoto,
METHODS
Japan) dissolved in 1 mL of ethanol [26]. During incuba-
Materials tion, pH was adjusted to 4.5 by HCl. The excessive ligand
was washed away sequentially with distilled water andCommercial PD fluids used in this study included: glu-
cose-based Dianeal PD-4 1.5 (1.36% glucose) and Dia- ethanol. The Boc group was then removed by incubating
the bead with 2 mL of trifluoroacetic acid at room tem-neal PD-4 4.25 (3.86% glucose) from Baxter Healthcare
(Round Lake, IL, USA); non-glucose Extraneal (7.5% perature for one hour, followed by evaporation of tri-
fluoroacetic acid. Ligand-coupled amino-bead was ob-icodextrin) and Nutrineal PD-4 (1.1% amino acid)
from Baxter Healthcare; and glucose-based PD-Solita tained after sequential washing with distilled water and
ethanol.(1.36% glucose) from Shimizu Medical (Tokyo, Japan)
and Midpeliq (1.36% glucose) from Terumo (Tokyo,
In vitro incubation experimentsJapan) both in a two compartment bag. A PD fluid with
the same composition as Dianeal PD-4 1.5 was pre- Peritoneal dialysis fluid (900 L) was fortified with
100 L of 50 mmol/L ligand compound solution inpared, sterilized with a 0.22 m-pore filter, and used as
the filter-sterilized PD fluid. 0.1 mol/L sodium phosphate buffer, pH 7.4, and incu-
bated at room temperature. PD fluid (6 mL) was alsoPeritoneal dialysis effluents after an eight hour dwell
also were obtained with informed consent from six non- incubated at room temperature with 0.13 g dried epoxy-
bead or amino-bead coupled with each ligand compound.diabetic patients (age range, 51 to 61 years; PD duration
range, 12 to 142 months) undergoing PD with Dianeal Mixing of the beads was achieved by a constant rotation
of the tubes at 25 times per minute. The dicarbonyl andPD-4 1.5.
N,N-diaminoguanidine monohydrochloride was pur- aldehydes contents of the mixture were determined after
0, 10, 30 and 60 minutes of incubation. PD fluid incubatedchased from ICN Biomedicals (Aurora, OH, USA), hy-
drazine monohydrate and l-cystine from Nacalai Tesque with the ligand-coupled bead was used for the chemical
analyses and for the cytotoxicity assay after removal of(Kyoto, Japan), hydroxylamine, oxamide, melamine, 2,3-
diaminopropionic acid monohydrochloride and 3,4-dia- beads by centrifugation at 1200  g for two minutes.
minobenzoic acid from Wako Pure Chemicals (Osaka,
Dicarbonyl and aldehyde measurementsJapan). AF-Epoxy-Toyopearl 650M (epoxy-bead) and
AF-Amino-Toyopearl 650 (amino-bead) were obtained The major dicarbonyl compounds in glucose PD fluid,
glyoxal (GO), methylglyoxal (MGO) and 3-deoxygluco-from TOSOH (Tokyo, Japan).
sone (3-DG), were determined as quinoxaline deriva-
Ligand coupling tives according to our previous method [20]. In brief,
50 L of sample was mixed with 5 L of 1 mmol/LAccording to their structure, the tested ligand com-
pounds were coupled with beads with either a free epoxy 2,3-butanedione (internal standard), 100 L of distilled
water, 80 L of 2 mol/L perchloric acid, and 40 L of 1%group (epoxy-bead) or a free amino group (amino-bead).
These beads have an average diameter of 25 m in the o-phenylenediamine. After the mixture was incubated
at 25C for three hours, quinoxaline derivatives weredry phase and of 90 m in the wet phase. For coupling
of N,N-diaminoguanidine monohydrochloride, hydra- analyzed by reversed-phase high-performance liquid chro-
matography (HPLC), using a C18 column (5 m, 4.6 zine monohydrate, hydroxylamine, oxamide, or mela-
mine to epoxy-bead [23], the ligand compound (10 mmol 250 mm; Waters, Milford, MA, USA), with an absorbance
detection at 315 nm. The buffer gradient used for elutioneach) dissolved in 10 mL of 2 N NaOH (except for
hydroxylamine in distilled water) was incubated at 45C was 15 to 30% buffer B (85 to 70% buffer A) in 30
minutes: buffer A, 0.10% trifluoroacetic acid; buffer B,for 24 hours with 1 g dried epoxy-bead in 1 mL of distilled
water. The excess ligand was washed away sequentially 80% acetonitrile containing 0.08% trifluoroacetic acid.
Other carbonyl compounds (aldehydes), that is, for-with distilled water and 1 mol/L NaCl. The remaining
epoxy residues were blocked by the incubation of the maldehyde, 5-hydroxymethylfuraldehyde, acetaldehyde,
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2-furaldehyde, were determined as 2,4-dinitrophenylhy- Total RCO measurement
drazone (DNPH) derivatives. Briefly, 100 L of the sam- The total RCOs present in PD effluent were deter-
ple was reacted at 25C for 30 minutes with an equal vol- mined as 2,4-dinitrophenyl hydrazone derivatives accord-
ume of 0.025% DNPH in 0.5 N HCl and subsequently ing to our previous method [27]. In brief, 200 L of
applied to a reversed-phase HPLC with a C18 column. 0.025% DNPH in 0.5 N HCl were added to 200 L of PD
Detection was at absorbance of 360 nm. The buffer gradi- effluent. After incubation at 30C for 30 minutes, 20 L
ent used for elution was 30 to 100% buffer B (70 to 0% of 1 mol/L acetone was added to react with excess DNPH
buffer A) in 55 minutes. at 30C for 10 minutes. The mixture was washed three
times with 200 L of hexane and the remaining aqueous
Assessment of the in vitro AGE generation layer was extracted with 200 L of octanol. The ab-
Peritoneal dialysis fluids were fortified with fatty acid- sorbance of the octanol layer was measured at a 360 nm
free bovine serum albumin (BSA; Sigma) to the final wavelength. The RCO content was calculated as mol/L
concentration of 30 mg/mL. BSA had been dissolved in using a standard curve between DNPH concentration
0.1 mol/L phosphate buffer (pH 7.4). They were steri- and absorbance [29]. In this method, the glucose-derived
lized with a 0.22-m-pore filter and incubated under air carbonyl group also reacts with DNPH. The glucose-
in sealed sterile 1.5 mL plastic tubes at 37C for one derived carbonyl content in samples were calculated on
week. The generation of a well-known AGE, Nε-carbox- the basis of the glucose concentration of samples and a
ylmethyllysine (CML), was then determined according standard curve of the carbonyl content obtained in dis-
to our previous method [27]. In brief, samples (100 L) tilled water containing various concentrations of glucose.
were diluted with 100 L 0.2 mol/L sodium borate, pH The level of RCOs other than glucose, hereafter referred
9.1, followed by addition of 20 L 1 mol/L NaBH4 in 0.1 to as total RCOs, was then calculated as the difference
N NaOH. Reduction was carried out for four hours at between total PD sample carbonyl and glucose-derived
room temperature and then protein precipitated by addi- carbonyl level.
tion of an equal volume of 20% trichloroacetic acid.
Cytotoxicity assayProtein was pelleted by centrifugation at 2,000  g for
five minutes. The supernatant was discarded and the A human epidermoid cell line A431 cells, purchased
pellet washed with 500 L 10% trichloroacetic acid. from ATCC (American Type Culture Collection, Ma-
Heavy labeled internal standards (d4-CML) were added nassas, VA, USA), was grown in Dulbecco’s modified
and the samples were hydrolyzed in 0.3 mL 6 N HCl at Eagle’s medium (DMEM) containing 10% fetal bovine
110C for 16 hours. The hydrolysates were dried under serum (FBS). A431 cells were taken from a subconfluent
a stream of nitrogen. CML in the hydrolysates were culture and inoculated in a 96-well tissue culture plate
measured as their N,O-trifluoroacetyl methyl esters by (Iwaki, Tokyo, Japan) at a density of 5,000 cells per well.
selected-ion monitoring gas chromatography/mass spec- Primary cultured human peritoneal mesothelial cells
trometry (GC/MS). isolated from omentum by the trypsin ethylenediamine-
tetraacetic acid (EDTA) digestion, according to the
Glucose and electrolytes measurement method of Hung et al [30], were kindly provided from
Glucose was measured by a kit according to the manu- Dr. Horiuchi T, University of East Asia, Yamaguchi,
facturer’s protocol (Glucose CII test; Wako). Sodium, Japan. They were cultured in M199 medium (Invitrogen,
calcium, and chloride contents were measured with Grand Island, NY, USA) containing 10% FBS, and iden-
i-STAT Portable Clinical Analyzer (East Windsor, NJ, tified immunochemically by the presence of vimentin and
USA). Lactate content was measured by using a kit ac- cytokeratin, and the absence of desmin and factor VIII-
cording to the manufacturer’s protocol (F-kit D-Lactic related antigen. Cells at passage two were used. They
acid/L-Lactic acid; Roche Diagnostics, Basel, Switzer- were taken from a subconfluent culture and inoculated
land). in a collagen-coated 96-well tissue culture plate (Becton,
Dickinson and Company, Franklin Lakes, NJ, USA) at
TNBS assay a density of 5000 cells per well.
The amount of hydrazide functional groups on hydra- Twenty-four hours after inoculation of both cell types,
zine-coupled epoxy-bead was estimated by the 2,4,6-tri- the growth medium was removed, and 100 L of various
nitrobenzenesulfonate (TNBS; Nacalai Tesque) assay PD fluids or of a RCO solution (10 mol/L GO, MGO,
according to the previous method [28]. In brief, the hy- and 3-DG and 10% FBS in DMEM or M199 medium,
drazine-coupled epoxy-bead emulsion (10 mg) in 0.3 mL pH 7.4) were added. In some experiments, the pH in
of 0.09 mol/L sodium tetraborate, pH 9.3, was fortified PD fluid was adjusted by 0.1 N NaOH in order to dissoci-
with 10 mg of TNBS, followed by the colorimetrical ate the effect of RCO content from that of pH. After
three hours, the test solution was replaced by fresh cul-analysis at the wavelength 420 nm.
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Table 1. Change in GO, MGO, and 3-DG levels in conventionalture medium in which cells were incubated for the next
PD fluid elicited by the addition of the tested compounds
18 hours. The viability of cells then was determined by a kit
Residual level %(Cell counting kit-8; Dojindo, Kumamoto, Japan) accord-
Compound GO MGO 3-DGing to the manufacturer’s recommendation. This assay in-
volves the detection of a highly water-soluble formazane Diaminoguanidine 19.52.5 5.0 31.50.4
Hydroxylamine 71.44.5 82.53.2 82.53.6dye utilizing 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophe-
Hydrazine 96.91.1 95.84.5 97.21.3nyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST-8) [31].
Meramine 88.75.4 92.65.6 84.64.4
Oxamide 92.43.2 90.02.2 81.31.8
2,3-Diaminopropionic acid 85.72.6 80.73.8 82.41.3
l-Cysteine 52.34.7 45.32.6 45.20.9Statistical analysis
3,4-Diaminobenzoic acid 27.64.1 52.03.4 30.23.1
Data are expressed as means  SD. The Student t test
Heat-sterilized 1.36% glucose PD fluid (900 L, pH 5.2) was incubated at
or analysis of variance (ANOVA) was used for a statistical room temperature for one hour with 100 L of the tested compound solution
(final concentration, 5 mmol/L) in 0.1. mol/L sodium phosphate buffer, pH 7.4.evaluation of significant variations. If a significant varia-
The GO, MGO, and 3-DG contents were determined by HPLC. Data are expressed
tion was indicated by the ANOVA, the Scheffe t test was as percentage of the levels initially present in PD fluid. They represent the mean
SD of three independent experiments. Abbreviations are in the Appendix.used to compare the values. A P value less than 0.05 was
considered statistically significant.
RESULTS
counterpart. Incubation of conventional PD fluid with
Affinity adsorption of dicarbonyls and aldehydes in diaminoguanidine- or hydrazine-coupled epoxy-bead de-
PD fluid creased the concentrations of dicarbonyl compounds in
a time-dependent (Fig. 2) and dose-dependent (data notConventional heat-sterilized glucose PD fluid contains
significant amounts of RCOs, including dicarbonyl com- shown) manner.
The generation of CML, an AGE, measured duringpounds (GO, 7.5 mol/L; MGO, 4.2 mol/L; and 3-DG,
50.2 mol/L) and aldehydes (formaldehyde, 5.7 mol/L; one week of incubation of heat-sterilized PD fluid, also
was significantly lower in hydrazine-coupled epoxy-bead5-hydroxymethylfuraldehyde, 12.6 mol/L; acetaldehyde,
247 L; and 2-furaldehyde, 4.8 L). These levels exceed pretreated PD fluid (5.08 0.09 nmol/mg albumin) than
in conventional PD fluid (6.87 0.08 mmol/mg albumin;markedly those of filtered-sterilized glucose PD fluid (GO,
MGO, 3-DG undetectable; formaldehyde, 1.7 mol/L; P  0.001).
Not only levels of dicarbonyl compounds (GO, MGO,5-hydroxymethylfuraldehyde, undetectable; acetaldehyde,
0.54 mol/L; and 2-furaldehyde, undetectable). and 3-DG) but also those of aldehydes (formaldehyde,
5-hydroxymethylfuraldehyde, acetaldehyde, and 2-fural-Eight agents were dissolved in heat-sterilized glucose
PD fluid. Their ability to lower the concentration of di- dehyde) are markedly higher in conventional heat-steri-
lized 1.36% glucose PD fluid than in the filter-sterilizedcarbonyl compounds was assessed after a 60-minute in-
cubation. Three of them (diaminoguanidine, l-cysteine, 1.36% glucose PD fluid. Addition of 0.13 g of hydrazine-
coupled epoxy-bead to heat-sterilized glucose PD fluidand 3,4-diaminobenoic acid) dramatically decreased the
concentrations of GO, MGO, and 3-DG. On a molar (6 mL) for one hour at room temperature returned the
levels of both dicarbonyls and aldehydes toward thosebasis, diaminoguanidine was the most efficient com-
pound (Table 1). The five other compounds, that is, hy- of filter-sterilized glucose PD fluid. Hydrazine-coupled
epoxy-beads were effective also in 3.86% glucose PDdroxylamine, hydrazine, meramine, oxamide, 2,3-diami-
nopropionic acid, proved ineffective. Kinetics analysis fluid (Table 3).
Incubation of heat-sterilized 1.36% glucose PD fluidrevealed that most of the RCO lowering effect was
achieved within the first 10 minutes (Fig. 1). with hydrazine-coupled epoxy-bead for one hour at room
temperature did not change its glucose, lactate, andCoupling of the tested compounds with the bead strik-
ingly modified their RCO trapping ability. Diaminogua- electrolytes contents, but raised its pH from 5.2 to 5.9
(Table 4).nidine coupled to epoxy-beads still decreased RCO lev-
els but less efficiently than in the fluid phase. l-cysteine The alkylamine bond between the hydrazine amino
group and the bead epoxy group is very tight, makingand 3,4-diaminobenzoic acid bound to beads lost most of
their RCO trapping potential, especially when compared any release of the hydrazine moiety during incubation
very unlikely. To confirm this, we autoclaved the hydra-with PD fluids incubated with the corresponding ligand
free beads (Table 2). By contrast, hydrazine and hydrox- zine-coupled epoxy-bead at 121C for 20 minutes and
measured the residual hydrazine residues on the beadylamine bound to beads proved potent RCOs trappers
although both drugs had little effect in the fluid phase by the TNBS assay. The initial hydrazine residues on
the bead (20.2  1.56 mol/mL) did not change (19.5 (Table 2). The hydrazine-coupled epoxy-beads were
markedly more effective than their diaminoguanidine 0.64 mol/mL).
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Fig. 1. Changes in GO, MGO and 3-DG levels elicited in conventional PD fluid by the addition of diaminoguanidine (A) and L-cysteine (B).
Abbreviations are in the Appendix. Heat-sterilized 1.36% glucose PD fluid (pH 5.2) was incubated for one hour at room temperature with various
concentrations of either diaminoguanidine or l-cysteine [() 1 mmol/L, () 5 mmol/L, () 10 mmol/L] dissolved in 0.1 mol/L sodium phos-
phate buffer, pH 7.4. The GO, MGO, and 3-DG levels were determined by a reverse HPLC. Data are expressed as percentage of the levels
initially present in fresh PD fluid. They represent the mean  SD of the three independent experiments.
Non-glucose PD fluids, icodextrin (Extraneal) and
amino acid (Nutrineal) solution, or the lactate-based
Table 2. Changes in GO, MGO and 3-DG levels elicited in glucose PD fluids in a two compartment bag (PD-Solitaconventional PD fluid by the addition of ligand-epoxy-beads
and Midpeliq) have a low dicarbonyl and aldehydeor –amino-beads
content. Still incubation with hydrazine-coupled epoxy-Residual level %
bead for one hour further reduced both dicarbonyl and
Compound GO MGO 3-DG aldehyde levels (Table 3).
Epoxy-beads Not only fresh PD fluid-derived RCOs, but also serum-
Diaminoguanidine 41.24.0 37.43.4 84.75.9
derived RCOs contribute to the genesis of peritonealHydroxylamine 29.45.2 20.34.5 90.56.3
Hydrazine 8.74.2 1.94.2 44.85.0 AGEs [5]. During peritoneal dwell, the initially present
Meramine 83.02.3 77.41.0 80.61.4 levels of GO, MGO and 3-DG as well as of glucose
Oxamide 97.71.0 98.91.1 94.71.0
fall markedly, whereas, by contrast, total RCO levelsLigand free beads 98.50.8 96.2 3.3 99.70.4
Amino-beads assessed by the DNPH method increase progressively in
2,3-Diaminopropionic acid 56.52.7 58.75.1 91.02.5 the PD effluent toward concentrations similar to those
l-Cysteine 59.10.9 49.31.0 97.31.1
observed in the plasma. At the end of the exchange, the3,4-Diaminobenzoic acid 56.12.6 42.92.8 97.61.8
Ligand free beads 63.12.7 73.13.3 97.51.6 peritoneal cavity of PD patients thus remains in a state
of severe overload of RCOs derived mainly from uremicHeat-sterilized 1.36% glucose PD fluid (6 mL, pH 5.2) was incubated at room
temperature for one hour with either 0.13 g dried epoxy-beads or amino-beads circulation [3]. Hydrazine-coupled epoxy-beads incu-
coupled with each ligand. G, MGO, and 3-DG contents were determined by
bated with PD effluents after an eight-hour dwell effec-HPLC. The reaction mixture with ligand free beads was also tested. Data are
expressed as percentage of the levels initially present in fresh PD fluid. They tively reduce total RCOs (Fig. 3). The fall averages 67%represent the mean  SD of three independent experiments. Abbreviations are
in the Appendix. after 60 minutes of incubation.
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Fig. 2. Changes of GO, MGO and 3-DG levels elicited in conventional PD fluid by the addition of diaminoguanidine-coupled or hydrazine-
coupled epoxy-beads. Heat-sterilized 1.36% glucose PD fluid (pH 5.5) was incubated for one hour at room temperature with 0.13 g dried
diaminoguanidine-coupled () or hydrazine-coupled epoxy-beads (). GO, MGO, and 3-DG were determined by a reverse HPLC. Data are
expressed as percentage of the levels initially present in fresh PD fluid. They represent the mean  SD of three independent experiments. **P 
0.05, *P  0.001 when compared with hydrazine-coupled epoxy-beads.
Table 3. Change of carbonyl compounds in PD fluid after hydrazine-coupled epoxy-bead treatment
Dianeal PD-4 1.5 Dineal PD-4 4.25 Extraneal Nutrineal PD-Solita Midpeliq
Bead            
FoA lmol/L 5.72.3 2.70.3 9.70.2 5.70.1 6.31.8 3.50.3 1.80.9 1.60.1 1.70.7 1.60.1 3.01.1 2.10.1
5-HMF lmol/L 12.62.7 4.10.8 24.20.6 8.80.2 2.10.5 0.40.1 UD UD 1.50.2 0.60.1 1.30.3 0.70.1
AcA lmol/L 24717 10.80.9 2763.1 99.91.1 68.24.5 4.50.5 13.81.3 4.70.6 7.90.7 2.90.5 19.11.0 3.20.9
3-DG lmol/L 50.24.2 24.22.0 78.32.7 66.62.3 2.91.1 1.10.1 UD UD 3.00.4 UD 11.80.8 3.90.4
2-FA lmol/L 4.81.6 1.80.2 6.00.2 3.30.1 1.20.3 UD UD UD UD UD 0.50.3 UD
GO lmol/L 7.50.2 0.60.1 16.81.0 2.80.1 2.40.6 0.30.1 UD UD UD UD 0.30.4 UD
MGO lmol/L 4.10.1 UD 6.40.6 0.40.1 2.30.3 1.50.2 UD UD UD UD UD UD
PD fluid (6 mL) was incubated at room temperature for one hour with 0.13 g dried hydrazine-coupled epoxy-bead. Data are expressed as the mean  SD of the
three independent experiments. Abbreviations are: FoA, formaldehyde; 5-HMF, 5-hydroxymethylfuraldehyde; AcA, acetaldehyde; 2-FA, 2-furaldehyde and UD, an
undetectable (0.2 mol/L).
Improvement of the PD fluid biocompatibility with lized PD fluid (20.9  0.17%) was significantly lower
hydrazine-coupled epoxy-bead treatment (P  0.001) than that of cells incubated with the filter-
sterilized PD fluid (58.4  4.02%), but improved afterThe clinical relevance of RCO entrapping agent-cou-
treatment with hydrazine-coupled epoxy-beads (48.1 pled bead hinges upon the demonstration of their ability
8.72%) (Fig. 4B). The pH of the heat-sterilized PD fluidto improve biocompatibility of heat-sterilized PD fluid.
(pH 5.2) was lower than that of filter-sterilized PD fluidA431 cells were cultured with either the heat-sterilized,
(pH 6.4). In order to dissociate the effect of RCO contentfilter-sterilized, or heat-sterilized PD fluid pretreated
from that of pH, the pH of heat-sterilized PD fluid waswith hydrazine-coupled epoxy-bead. After a three hour
adjusted to pH 5.9, which is equivalent to that of heat-culture, cytotoxicity was assessed (Fig. 4A). The viability
sterilized PD fluid pretreated with hydrazine-coupledof cells incubated with the heat-sterilized PD fluid
epoxy-bead. The pH adjustment significantly improved(12.8  0.69%) was significantly lower (P  0.001) than
the viability of the cells (36.1  3.51%, P  0.001 vs.that of cells incubated with the filter-sterilized PD fluid
heat-sterilized PD fluid without the bead treatment;(65.7  4.65%). Treatment of the heat-sterilized PD
Fig. 4B). The pH of PD fluid is thus an important factorfluid with hydrazine-coupled epoxy-beads returned its
in the biocompatibility assay. Still, the low pH per se doescytotoxicity (60.7  1.09%) to the level observed in the
not fully account for the cytotoxicity of heat-sterilizedfilter-sterilized PD fluid.
PD fluid: the viability of cells incubated with the heat-The improved biocompatibility of heat-sterilized PD
sterilized PD fluid at pH 5.9 remained significantly (P fluid treated by hydrazine-coupled epoxy-beads was con-
0.05) below that of cells incubated with the heat-steri-firmed in primary cultured human peritoneal mesothelial
cells. The viability of cells incubated with the heat-steri- lized PD fluid pretreated with hydrazine-coupled epoxy-
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Table 4. Change of the composition of conventional PD fluid after treatment with hydrazine-coupled epoxy-bead
Glucose Lactate Sodium Calcium Chloride
Reaction time
minutes pH g/L mmol/L
0 5.210.06 13.50.32 3.640.04 1330.89 0.930.03 81.31.53
10 5.890.23 13.30.06 3.590.28 1321.73 0.920.05 80.70.58
30 5.850.18 13.20.20 3.650.19 1310.58 0.920.06 80.01.0
60 5.880.20 13.20.16 3.630.24 1310.10 0.920.04 79.30.50
Heat-sterilized 1.36% glucose PD fluid (6 mL, pH 5.2) was incubated at room temperature for one hour with 0.13 g dried hydrazine-coupled epoxy-bead. Data
are expressed as the mean  SD of three independent experiments.
DISCUSSION
The long-term success of PD hinges upon the preserva-
tion of the peritoneal membrane’s permeability charac-
teristics. The hypothesis that RCOs accumulating in the
peritoneal cavity may contribute to the deterioration of
the peritoneum has stimulated a number of developments.
They include the production of solutes with a lower glu-
cose derived RCOs content [9–11] and the lowering of
RCOs by the addition of AGE inhibitory substances
[12–15]. The latter approach is limited, however, by the
potential systemic toxicity of AGE inhibitors, for exam-
ple, pyridoxal entrapment [20], diffusing from the perito-
neal cavity.
This study evaluated the AGE lowering potential of
eight substances bound to artificial beads, whose size
precludes their diffusion from the peritoneal cavity into
the systemic circulation. Diaminoguanidine, l-cysteine
and 3,4-diaminobenzoic, dissolved in heat-sterilized glu-
cose PD fluid, efficiently lowered RCO levels. Binding
with epoxy-beads, by contrast, modified their RCO low-
Fig. 3. Changes of total carbonyl concentration in PD effluents elicited
ering characteristics so that only diaminoguanidine andby the addition of hydrazine-coupled epoxy-beads. PD effluents after
an eight hour dwell, obtained from patients undergoing PD with 1.36% hydrazine remained effective. This discrepancy probably
glucose PD fluid, were incubated for one hour at room temperature results from structure modifications induced by solidifi-
with 0.13 g dried hydrazine-coupled epoxy-bead. After ultrafiltration
cation. Overall, the most efficient compound was clearlythrough a filter with a 5000 D cut-off value, the sample was incubated
with DNPH, and RCOs (other than glucose) were determined by a hydrazine bound to epoxy-beads: its addition to heat-
spectrophotometric assay. Samples processed similarly but without sterilized glucose PD fluid decreased not only dicarbonyl,
DNPH treatment were used as blanks. Data from three PD patients
but also cytotoxic aldehyde levels to those present inare expressed as mean  SD. **P  0.05 vs. compared with untreated
PD effluent. filter-sterilized fluid. Added to glucose free PD fluid (ico-
dextrin or amino acid solutions) or to the dual bag sys-
tem, it further lowered the already low RCO content.
The hydrazine-coupled epoxy-beads do not modifybead. This observation suggests a contribution of RCOs
the PD solution including its lactate level except for anto cytotoxicity, independent of pH.
instant rise of pH from 5.2 to 5.9, probably due to theThe direct involvement of RCOs in the cytotoxicity
basophilic properties of hydrazine beads. This additionalassay was demonstrated both in A431 cells and in pri-
characteristic further protects the peritoneum against themary cultured human peritoneal mesothelial cells incu-
deleterious effect of acidic PD fluids.bated with and without a RCO solution containing 10
The hydrazine-coupled epoxy-beads are theoreticallymol/L GO, MGO, and 3-DG, concentrations roughly
stable and unlikely to release their toxic ligand (hydra-equivalent to those present in heat-sterilized glucose PD
zine), because the alkylamine linkage between the beadfluid (Fig. 4C). Expressed as a percentage of values ob-
epoxy group and ligand amine group is very strong. Ourserved in the absence of RCOs, the viability of A431
TNBS assays indeed confirm that dissociation of ligand(78.9  4.78%) and of primary cultured human perito-
does not occur even under rigorous incubation condi-neal mesothelial cells (84.1  8.42%) incubated with a
tions, for example, at 121C for 20 minutes.RCO solution decreased significantly (P  0.001 and
P  0.05, respectively). Of note is the finding that hydrazine-coupled epoxy-
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Fig. 4. Effects of hydrazine-coupled epoxy-bead treated PD fluid or an RCO solution on the viability of A431 cells and of primary cultured
human peritoneal mesothelial cells (HMC). A431 cells (A) or HMC (B) were cultured in the presence of either filter-sterilized (pH 6.4), or heat-
sterilized (pH 5.2) PD fluids treated with hydrazine-coupled epoxy-bead (pH 5.9), or heat-sterilized PD fluid adjusted to pH 5.9. After a 3 hour
(A431) or 12 hour (HMC) culture, the incubation medium was replaced by fresh culture medium for the subsequent 18 hours. The viability of
cells was then determined. Results are expressed as percentage of control (medium alone) and represent the mean  SD of three independent
experiments. **P  0.05, *P  0.001 vs. heat-sterilized PD fluid (pH 5.2). ‡P  0.05 vs. heat-sterilized PD fluids treated with hydrazine-coupled
epoxy-bead. There is no significant difference between filter-sterilized PD fluids and heat-sterilized PD fluids treated with hydrazine-coupled epoxy-
bead. A431 cells or HMC (C ) were cultured in the presence of a RCO solution (10 mol/L GO, MGO, and 3-DG and 10% FBS in the medium,
pH 7.4), and the viability of cells was determined. Results are expressed as percentage of control (medium alone) and represent the mean  SD
of three independent experiments. **P  0.05, *P  0.001 vs. control medium.
beads ameliorate the cytotoxicity of dialysates. Survival formulation requires relatively large amounts of bead
for complete RCO trapping: the surface area of the beadratios of A431 cells and primary cultured human perito-
neal mesothelial cells incubated with either conventional and the attendant increase in ligand binding need to
be optimized. Further technical developments, includingheat-sterilized or filter-sterilized PD fluid, or with PD
fluid treated with the hydrazine-beads were compared. the design of an appropriate cartridge to house the bead,
are also necessary to test the practicality and the costWhile heat-sterilized PD fluid induced cell death, hydra-
zine-coupled epoxy-beads added to the PD fluid im- effectiveness of this approach.
The hydrazine-coupled epoxy-beads also lowered theproved cell survival.
The beneficial effect of hydrazine-coupled epoxy- total RCO content in PD effluent. Thus, they are able
to lower not only the dicarbonyls, MGO and GO in freshbeads on PD fluid cytotoxicity relies on two factors, the
rise in PD fluid pH and the binding of RCOs. The pH PD fluid, but also the RCOs of uremic blood origin
accumulating in the PD effluent during dwell time. Thiseffect is demonstrated by the decrease in cytotoxicity of
heat sterilized glucose PD fluid whose pH has been raised potential, applied to recycled PD fluid [32], is of consider-
able interest, as it should enhance RCO removal byto levels observed after the addition of hydrazine-cou-
pled epoxy-beads. A specific cytotoxicity of RCOs is dem- newer techniques of peritoneal dialysis. Here again, test-
ing this hypothesis will require the development of ap-onstrated after their addition to cultured A431 and HMC.
The powerful trapping of glucose derived RCOs by propriate bead containing cartridges.
In conclusion, the present study demonstrates that ithydrazine bound beads raises the possibility to improve
heat-sterilized PD fluid: RCOs present in glucose con- is possible to remove RCOs whether in fresh or in spent
dialysate, by beads linked compounds. As these com-taining PD fluid are returned to levels achieved through
filter-sterilization or further lowered in amino acid or pounds are not administered in the body, their potential
systemic toxicity is prevented and PD fluid biocompati-icodextrin PD fluid. As a result, the PD fluid biocompati-
bility is markedly improved. The tight bond with the bility is improved. Hydrazine-coupled epoxy-beads thus
provide a new approach to RCO removal from PD fluid.bead prevents any spillage of hydrazine in the PD fluid
and hence into the systemic circulation. Still, the current Its clinical applicability requires further studies.
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